Spyre Therapeutics, Inc. · NASDAQ:SYRE

Burrows Scott L sold 25,732 Spyre Therapeutics, Inc. shares (Form 4)

Traded Sep 1 to Sep 2, 2026 · Filed Sep 3, 2026

From Sep 1 to Sep 2, 2026, Burrows Scott L (Chief Financial Officer) sold 25,732 Spyre Therapeutics, Inc. shares at an average US$88.75 for US$2.28M under a trading plan, leaving 79,762 shares. Filed Sep 3, 2026 (Form 4).

Sold
25,732 shares
Price
US$88.75 average (US$86.25 to US$89.35)
Value
US$2.28M
Holding after
79,762 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Common StockOption exercise7,500US$14.50105,494Direct
Sep 1, 2026Common StockSale900US$86.25104,594Direct
Sep 1, 2026Common StockSale4,384US$87.11100,210Direct
Sep 1, 2026Common StockSale2,016US$88.0398,194Direct
Sep 1, 2026Common StockSale200US$89.0497,994Direct
Sep 2, 2026Common StockSale18,232US$89.3579,762Direct

Source

View original at SEC

Related